A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony TC Chan, MD, FRCP
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong
Principal Investigator - Roger KC Ngan, FRCR
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital
Hong Kong, Hong Kong
- Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
- Department of Clinical Oncology, Queen Elizabeth Hospital
Hong Kong, Hong Kong
- Department of Clinical Oncology, Queen Mary Hospital
Hong Kong, Hong Kong
- Department of Clinical Oncology, Tuen Mun Hospital
Hong Kong, Hong Kong
- Department of Oncology, Princess Margaret Hospital
Hong Kong, Hong Kong
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Sept 2006
- Primary completion
- 26 Oct 2021
- Completion
- 26 Oct 2021
- Last update posted
- 17 Feb 2022
- Registered enrollment
- 104
- Registry id
- NCT00370890
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.